Anthem Biosciences News

Anthem Biosciences to attend investor meets

Anthem Biosciences will attend Nomura and Citi conferences in June 2026. No UPSI will be discussed.

Anthem Biosciences posts Q4FY26 earnings call

Anthem Biosciences has released the audio recording of its Q4 and FY26 earnings call held on May 20, 2026. The recording covers audited standalone and consolidated results.

Anthem Biosciences Schedules Q4 FY26 Earnings Call

Anthem Biosciences has scheduled its Q4 & FY2026 earnings conference call for May 20, 2026, at 11:00 AM IST, to discuss audited standalone and consolidated financial results.

Anthem Biosciences Board Meet on May 19 for FY26 Results

Anthem Biosciences schedules Board meeting on May 19, 2026 to approve audited standalone and consolidated financial results for Q4 and FY26, and consider final dividend.

Anthem Biosciences appoints new auditors, approves upside sharing

Anthem Biosciences Board appoints M/s. S. R. Batliboi & Associates LLP as statutory auditors for 5 years from FY2026-27 to FY2031-32. Board also approves upside sharing arrangement with Viridity Tone LLP involving INR 1,276.83 million payment to promoters.